litterguard lt-c formulation: each (2 ml) dose contains: escherichia coli k99 + f41 adhesin (nadc 1471 strain) ...................>1.36 rp 987p adhesin (nadc 1413 strain) ............................. >1.44 rp k88 adhesin (pps002 strain).................>1.41 rp ltb adhesin(nl-1001 strain) ...................... >1.62 rp k99 adhesin (nl-1005 strain) .................>1.48 rp clostridium perfringens type c antigen (nl-1003 strain) ...........>10 iau rp-relative potency iau-international antitoxin unit suspension for injection (im/sc)
zoetis philippines, inc.; distributor: zoetis philippines, inc. - inactivated escherichia coli fimbrial adhesins , clostridium perfringens vaccine (vet.) - suspension for injection (im/sc) - formulation: each (2 ml) dose contains: escherichia coli k99 + f41 adhesin (nadc 1471 strain) ...................>1.36 rp 987p adhesin (nadc 1413 strain) ............................. >1.44 rp k88 adhesin (pps002 strain).................>1.41 rp ltb adhesin(nl-1001 strain) ...................... >1.62 rp k99 adhesin (nl-1005 strain) .................>1.48 rp clostridium perfringens type c antigen (nl-1003 strain) ...........>10 iau rp-relative potency iau-international antitoxin unit
prosystem® rce formulation: each dose contains: porcine rotavirus, serogroup a (serotype g4 & g5)....... 26.2 login tcid50 escherichia coli (strain 80-2575) k88 21.3 rp (strain nadc 1471) k99.. 21.3 rp (strain nadc 1413) 987p. 1.2 rp (strain nadc 1471) f41.. ≥1.4 rp clostridium perfringens, type c (strain 4407)... ≥10 iau rp relative potency jau – international antitoxin units tcid – tissue culture infectious dose freeze-dried vaccine freeze-dried vaccine. for solution (im)
msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - modified live porcine rotavirus , clostridium modified live porcine rotavirus , clostridium perfringens , escherichia coli vaccine (vet.) - freeze-dried vaccine freeze-dried vaccine. for solution (im) - formulation: each dose contains: porcine rotavirus, serogroup a (serotype g4 & g5)....... 26.2 login tcid50 escherichia coli (strain 80-2575) k88 21.3 rp (strain nadc 1471) k99.. 21.3 rp (strain nadc 1413) 987p. 1.2 rp (strain nadc 1471) f41.. ≥1.4 rp clostridium perfringens, type c (strain 4407)... ≥10 iau rp relative potency jau – international antitoxin units tcid – tissue culture infectious dose
inmunair 17.5 formulation: each 1 ml contains: propionibacterium acnes (czv-cmc strain) ................. 0.17 mg escherichia coli lipopolysaccharide.............. 0.05 mg oral suspension
vet specialists, inc.; distributor: vet specialists, inc. - inactivated propionibacterium acnes , escherichia coli lipopolysaccharide (vet.) - oral suspension - formulation: each 1 ml contains: propionibacterium acnes (czv-cmc strain) ................. 0.17 mg escherichia coli lipopolysaccharide.............. 0.05 mg
porcilis porcoli df formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) ....
n/a; importer: msd animal health (phils.), inc.; distributor: n/a - inactivated escherichia coli fimbrial adhesin , heat labile toxoid (lt) toxoid vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) .... > 400 u f4ac (k8
coliprotec f4/f18 live non-pathogenic escherichia coli (f4ac) (08:k87 strain)......... >1.3 x 10^x.0 cfu (f18ac) (o141:k94 strain) ........>2.8 x 10^x.0 cfu cfu-colony forming unit freeze-dried powder for oral suspension
elanco philippines, inc.; distributor: elanco philippines, inc. - live escherichia coli (e. coli) vaccine (vet.) - freeze-dried powder for oral suspension - live non-pathogenic escherichia coli (f4ac) (08:k87 strain)......... >1.3 x 10^x.0 cfu (f18ac) (o141:k94 strain) ........>2.8 x 10^x.0 cfu cfu-colony forming unit
scourguard 4(k)
zoetis new zealand limited - escherichia coli k99 (pili); bovine rotavirus (inactivated); bovine coronavirus (inactivated) - escherichia coli k99 (pili) 0 vaccine; bovine rotavirus (inactivated) 0 vaccine; bovine coronavirus (inactivated) 0 vaccine - vaccine
suiseng coli / c inj. susp. i.m. vial
laboratorios hipra s.a. - escherichia coli f6 fimbrial adhesin ; eschericia coli lt-enterotoxoïd ; escherichia coli f4ac fimbrial adhesin ; escherichia coli f4ab fimbrial adhesin ; clostridium novyi toxoid ; escherichia coli f5 fimbrial adhesin ; clostridium perfringens type c toxoid - suspension for injection - clostridium perfringens; clostridium novyi toxoid; escherichia coli enterotoxin lt; escherichia coli adhesins - escherichia + clostridium - pig
startvac
laboratorios hipra s.a. - escherichia coli j5 inactivated, staphylococcus aureus (cp8) strain sp 140 inactivated, expressing slime-associated antigenic complex - immunologicals for bovidae - cattle (cows and heifers) - for herd immunisation of healthy cows and heifers, in dairy cattle herds with recurring mastitis problems, to reduce the incidence of sub-clinical mastitis and the incidence and the severity of the clinical signs of clinical mastitis caused by staphylococcus aureus, coliforms and coagulase-negative staphylococci.the full immunisation scheme induces immunity from approximately day 13 after the first injection until approximately day 78 after the third injection (equivalent to 130 days post-parturition).
poulvac e.coli
zoetis australia pty ltd - live aroa-gene deleted escherichia coli,type o78,ec34195 - misc. vaccines or anti sera - live aroa-gene deleted escherichia coli,type o78,ec34195 vaccine-microbial active 0.0 u - immunotherapy
bovigen scour emulsion for injection for cattle
forte healthcare ltd - bovine coronavirus strain c-197 (inactivated); bovine rotavirus strain tm-91, serotype g6p1 (inactivated). ; escherichia coli strain ec/17, (inactivated) expressing f5(k99) adhesin - emulsion for injection - . - bovine rotavirus + bovine coronavirus + escherichia - cattle - immunological - inactivated vaccine